Mutant huntingtin expression in clonal striatal cells: Dissociation of inclusion formation and neuronal survival by caspase inhibition

被引:0
作者
Kim, M
Lee, HS
LaForet, G
McIntyre, C
Martin, EJ
Chang, P
Kim, TW
Williams, M
Reddy, PH
Tagle, D
Boyce, FM
Won, L
Heller, A
Aronin, N
DiFiglia, M
机构
[1] Massachusetts Gen Hosp, Dept Neurol, Boston, MA 02114 USA
[2] Univ Massachusetts, Med Ctr, Dept Med, Worcester, MA 01655 USA
[3] Univ Massachusetts, Med Ctr, Dept Cell Biol, Worcester, MA 01655 USA
[4] NIH, Bethesda, MD 20892 USA
[5] Univ Chicago, Dept Pharmacol & Physiol Sci, Chicago, IL 60637 USA
关键词
NH2-terminal huntingtin fragments; nuclear inclusions; cytoplasmic inclusions; full-length huntingtin; apoptosis; apoptotic bodies; membrane blebbing; Z-VAD-FMK; Z-DEVD-FMK; striatal hybrid cells;
D O I
暂无
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Neuronal intranuclear inclusions are found in the brains of patients with Huntington's disease and form from the polyglutamine-expanded N-terminal region of mutant huntingtin. To explore the properties of inclusions and their involvement in cell death, mouse clonal striatal cells were transiently transfected with truncated and full-length human wild-type and mutant huntingtin cDNAs. Both normal and mutant proteins localized in the cytoplasm, and infrequently, in dispersed and perinuclear vacuoles. Only mutant huntingtin formed nuclear and cytoplasmic inclusions, which increased with polyglutamine expansion and with time after transfection. Nuclear inclusions contained primarily cleaved N-terminaI products, whereas cytoplasmic inclusions contained cleaved and larger intact proteins. Cells with wild-type or mutant protein had distinct apoptotic features (membrane blebbing, shrinkage, cellular fragmentation), but those with mutant huntingtin generated the most cell fragments (apoptotic bodies). The caspase inhibitor Z-VAD-FMK significantly increased cell survival but did not diminish nuclear and cytoplasmic inclusions. In contrast, Z-DEVD-FMK significantly reduced nuclear and cytoplasmic inclusions but did not increase survival. A series of N-terminal products was formed from truncated normal and mutant proteins and from full-length mutant huntingtin but not from full-length wild-type huntingtin. One prominent N-terminal product was blocked by Z-VAD-FMK. In summary, the formation of inclusions in clonal striatal cells corresponds to that seen in the HD brain and is separable from events that regulate cell death. N-terminal cleavage may be linked to mutant huntingtin's role in cell death.
引用
收藏
页码:964 / 973
页数:10
相关论文
共 31 条
  • [11] Eldadah BA, 1997, J NEUROSCI, V17, P6105
  • [12] Cleavage of huntingtin by apopain, a proapoptotic cysteine protease, is modulated by the polyglutamine tract
    Goldberg, YP
    Nicholson, DW
    Rasper, DM
    Kalchman, MA
    Koide, HB
    Graham, RK
    Bromm, M
    KazemiEsfarjani, P
    Thornberry, NA
    Vaillancourt, JP
    Hayden, MR
    [J]. NATURE GENETICS, 1996, 13 (04) : 442 - 449
  • [13] The influence of Huntingtin protein size on nuclear localization and cellular toxicity
    Hackam, AS
    Singaraja, R
    Wellington, CL
    Metzler, M
    McCutcheon, K
    Zhang, TQ
    Kalchman, M
    Hayden, MR
    [J]. JOURNAL OF CELL BIOLOGY, 1998, 141 (05) : 1097 - 1105
  • [14] Suppression of aggregate formation and apoptosis by transglutaminase inhibitors in cells expressing truncated DRPLA protein with an expanded polyglutamine stretch
    Igarashi, S
    Koide, R
    Shimohata, T
    Yamada, M
    Hayashi, Y
    Takano, H
    Date, H
    Oyake, M
    Sato, T
    Sato, A
    Egawa, S
    Ikeuchi, T
    Tanaka, H
    Nakano, R
    Tanaka, K
    Hozumi, I
    Inuzuka, T
    Takahashi, H
    Tsuji, S
    [J]. NATURE GENETICS, 1998, 18 (02) : 111 - 117
  • [15] Transglutaminase action imitates Huntington's disease: Selective polymerization of huntingtin containing expanded polyglutamine
    Kahlem, P
    Green, H
    Djian, P
    [J]. MOLECULAR CELL, 1998, 1 (04) : 595 - 601
  • [16] APOPTOSIS - BASIC BIOLOGICAL PHENOMENON WITH WIDE-RANGING IMPLICATIONS IN TISSUE KINETICS
    KERR, JFR
    WYLLIE, AH
    CURRIE, AR
    [J]. BRITISH JOURNAL OF CANCER, 1972, 26 (04) : 239 - +
  • [17] KIM M, 1999, IN PRESS NEUROSCIENC
  • [18] A cellular model that recapitulates major pathogenic steps of Huntington's disease
    Lunkes, A
    Mandel, JL
    [J]. HUMAN MOLECULAR GENETICS, 1998, 7 (09) : 1355 - 1361
  • [19] A NOVEL GENE CONTAINING A TRINUCLEOTIDE REPEAT THAT IS EXPANDED AND UNSTABLE ON HUNTINGTONS-DISEASE CHROMOSOMES
    MACDONALD, ME
    AMBROSE, CM
    DUYAO, MP
    MYERS, RH
    LIN, C
    SRINIDHI, L
    BARNES, G
    TAYLOR, SA
    JAMES, M
    GROOT, N
    MACFARLANE, H
    JENKINS, B
    ANDERSON, MA
    WEXLER, NS
    GUSELLA, JF
    BATES, GP
    BAXENDALE, S
    HUMMERICH, H
    KIRBY, S
    NORTH, M
    YOUNGMAN, S
    MOTT, R
    ZEHETNER, G
    SEDLACEK, Z
    POUSTKA, A
    FRISCHAUF, AM
    LEHRACH, H
    BUCKLER, AJ
    CHURCH, D
    DOUCETTESTAMM, L
    ODONOVAN, MC
    RIBARAMIREZ, L
    SHAH, M
    STANTON, VP
    STROBEL, SA
    DRATHS, KM
    WALES, JL
    DERVAN, P
    HOUSMAN, DE
    ALTHERR, M
    SHIANG, R
    THOMPSON, L
    FIELDER, T
    WASMUTH, JJ
    TAGLE, D
    VALDES, J
    ELMER, L
    ALLARD, M
    CASTILLA, L
    SWAROOP, M
    [J]. CELL, 1993, 72 (06) : 971 - 983
  • [20] Processing/activation of at least four interleukin-1 beta converting enzyme-like proteases occurs during the execution phase of apoptosis in human monocytic tumor cells
    MacFarlane, M
    Cain, K
    Sun, XM
    Alnemri, ES
    Cohen, GM
    [J]. JOURNAL OF CELL BIOLOGY, 1997, 137 (02) : 469 - 479